Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MM
- Status
- UNKNOWN
- Phase
- PHASE1
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3